跳至主要内容
临床试验/NCT02991001
NCT02991001已完成不适用

The Effect of Hydrodissection for Patients With Carpal Tunnel Syndrome

Tri-Service General Hospital1 个研究点 分布在 1 个国家目标入组 34 人开始时间: 2017年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
34
试验地点
1
主要终点
Change from baseline of severity of symptoms and functional status on 2nd week, 1st, 2nd, 3rd and 6th month after injection

研究概览

简要总结

Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy with involving compression of the median nerve in the carpal tunnel. Rather than other progressive disease, CTS is characterized by remission and recurrence. The hydrodissection could decrease the entrapment of nerve to restore blood supply. Despite the hydrodissection was pervasively used in clinical practice, current researches contain small participant without control group or randomized leading to foreseeable selection bias. The investigators design a randomized, double-blind, controlled trail to assess the effect after ultrasound-guided hydrodissection in patients with CTS.

详细描述

After obtaining written informed consent, patients with bilateral CTS will been randomized into intervention and control group. Participants in intervention group received one-dose ultrasound-guided hydrodissection and control side received one-dose ultrasound-guided injection at subcutaneous layer beyond carpal tunnel. No additional treatment after injection through the study period. The primary outcome is visual analog scale (VAS) and secondary outcomes include Boston Carpal Tunnel Syndrome Questionnaire (BCTQ), cross-sectional area (CSA) of the median nerve, sensory nerve conduction velocity of the median nerve, and finger pinch strength. The evaluation was performed pretreatment as well as on the 2nd week, 1st, 2nd and 3rd month after the treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 20-80 year-old.
  • Diagnosis was confirmed using an electrophysiological study

排除标准

  • Coagulopathy
  • Pregnancy
  • Inflammation status
  • Cervical radiculopathy
  • Polyneuropathy, brachial plexopathy
  • Thoracic outlet syndrome
  • Previously undergone wrist surgery or steroid injection for CTS

研究组 & 干预措施

Normal saline hydrodissection

Experimental

Ultrasound-guided hydrodissection with normal saline between carpal tunnel and median nerve.

干预措施: Ultrasound-guided hydrodissection (Procedure)

Normal saline hydrodissection

Experimental

Ultrasound-guided hydrodissection with normal saline between carpal tunnel and median nerve.

干预措施: Ultrasound (Device)

Normal saline hydrodissection

Experimental

Ultrasound-guided hydrodissection with normal saline between carpal tunnel and median nerve.

干预措施: Normal Saline (Drug)

Normal saline

Placebo Comparator

Ultrasound-guided injection with normal saline at subcutaneous layer beyond the carpal tunnel region

干预措施: Placebo ultrasound-guided injection (Procedure)

Normal saline

Placebo Comparator

Ultrasound-guided injection with normal saline at subcutaneous layer beyond the carpal tunnel region

干预措施: Ultrasound (Device)

Normal saline

Placebo Comparator

Ultrasound-guided injection with normal saline at subcutaneous layer beyond the carpal tunnel region

干预措施: Normal Saline (Drug)

结局指标

主要结局

Change from baseline of severity of symptoms and functional status on 2nd week, 1st, 2nd, 3rd and 6th month after injection

时间窗: Pre-treatment, 2nd week, 1st, 2nd and 3rd month after injection

Boston carpal tunnel syndrome questionnaire (BCTQ) is a frequently used patient-based questionnaire for measurement of CTS which encompasses two components. In total, 11 questions and 8 items were evaluated to rate the symptom severity scale (SSS) and functional status scale (FSS), respectively. Both subscales range from 1 to 5 with a higher score indicating a higher degree of disability. The mean of total SSS and FSS divided with each item score were used for further analysis.

次要结局

  • Change from baseline of pain on 2nd week, 1st, 2nd and 3rd month after injection(Pre-treatment, 2nd week, 1st, 2nd , 3rd and 6th month after injection)
  • Change from baseline of conduction velocity, amplitude of median nerve on 2nd week, 1st, 2nd and 3rd month after injection(Pre-treatment, 2nd week, 1st, 2nd , 3rd and 6th month after injection)
  • Change from baseline of cross-sectional area of the median nerve on 2nd week, 1st, 2nd and 3rd month after injection(Pre-treatment, 2nd week, 1st, 2nd , 3rd and 6th month after injection)
  • Change from baseline of finger pinch on 2nd week, 1st, 2nd and 3rd month after injection(Pre-treatment, 2nd week, 1st, 2nd, 3rd and 6th month after injection)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yung-Tsan Wu

Attending Physician of Department of Physical Medicine and Rehabilitation

Tri-Service General Hospital

研究点 (1)

Loading locations...

相似试验